This test for systemic lupus erythematosus utilizes a novel liposome composition entrapping the cation-responsive red dye Arsenazo Ill. In dilutions of normal sera the liposome membranes undergo a rearrangement when divalent cations are added, resulting in the release of the encapsulated dye and the rapid formation of a stable blue cation-dye complex. Microliter amounts of sera from patients with active lupus stabilize the liposome preparation such that the vesicles remain intact in the presence of the added divalent cations and thus maintain their red color for extended periods. The assay requires 1-mm incubations in sera at room temperature and can be performed with standard microtiter plates, allowing the screening of large numbers of serum samples in a short time. Moreover, the unique absorption spectra of the complexed and uncomplexed dye allow for quantification of results. substrate represents the accepted laboratory screening procedure for the diagnosis of SLE (1). Although this is a sensitive test, registering "abnormal" in >95% of patients with SLE (2), a positive result has virtually no specificity, serum ANA frequently being present in many chronic connective-tissue diseases; in the elderly, in psychiatric inpatients, and in relatives of SLE patients; in response to various drug therapies; and in a substantial number of healthy controls (1). Standard practice in most centers is to follow up positive tests for ANA with assays of high specificity for SLE, most notable of which are the various tests for antibody to double-stranded DNA (ds DNA) (3), a test of particular value because patients with these antibodies are more likely to manifest clinically active SLE or renal involvement (4).
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Although anti-ds DNA is the hallmark antibody of SLE, the site of antigenicity remains unclear. Double-stranded DNA is a weak immunogen in animal models (5). Recently, monoclonal antibodies to DNA have been shown to react with a wide range of both natural and synthetic polynucleotides (6). Additionally, phospholipids (including cardiolipin, phosphatidylglycerol, and phosphatidic acid) have been demonstrated to bind competitively to monoclonal anti-DNA antibodies.
Further, the antinuclear reaction of a single monoclonal lupus autoantibody is specifically inhibited by cardiolipin (7). The implication of this is that a common phosphate-ester epitope represents the principal site of antigemc recognition of anti-ds DNA (8). By exploiting the fact that cardiolipin serves as an antigen for circulating SLE autoantibodies, one can design a liposomebased assay system, containing cardiolipin as a major constituent, for the detection of such antibodies. The system presented here takes advantage of the fact that cardiolipin can be induced to rearrange from a bilayer to a nonbilayer form in the presence of divalent cations, thereby destabilizing the liposome structure (9). By encapsulating a cationresponsive dye inside the liposome, the binding of antibodies and subsequent stabilization of the liposomal structure to the perturbative effects of added divalent cations can be detected by an inhibition of the color change that results from the formation of a cation-dye complex upon breakdown of the liposomal barrier. had been added to all 40 wells, we could determine which liposome and magnesium concentrations resulted in the largest difference between the red seen in the SLE wells and the blue seen in the normal wells.
Materials and Methods

Lipids
Spectrophotometric methods.
Spectral scans of AlIT entrapped in liposomes in the presence and absence of magnesium and in the presence and absence of serum (SLE or normal) were generated with a dual-beam spectrophotometer blanked against AIll-liposomes.
We quantified the color changes from red (lupus sera + Mg2) to blue (normal sera + Mg2) at 610 nm.
Binding of serum proteins to liposomes.
Three liposome compositions were used to demonstrate the binding of normal and SLE serum to the membranes. Liposome preparation A contained POPC/cholesterol/DPPG/a-tocopherol, 7/ 1.9/1.0/0.1 (mol ratio). Preparation B contained the same lipid components as A but in a 3/1.9/5.0/0.1 mol ratio. For sodium dodecyl sulfate-polyacrylamide slab gel electrophoresis we followed the procedure of Laemmli (12), using a 120 g/L polyacrylamide separating gel containing 3.2 g of bisacrylamide per liter. Gels were formed in a 12 x 12 cm slab apparatus and electrophoresed for 5-6 h at a constant current of 25 mA. We stained the gels with Coomassie Brilliant Blue (2 g/L) and destained with a solution of acetic acid, methanol, and water.
Patients
We obtained single serum samples from 74 patients attending the outpatient Rheumatology Clinics of the Rutgers Medical School. These included 21 patients who met revised criteria for the classification of SLE (13), 13 with seropositive rheumatoid arthritis, 14 who met preliminary criteria for the classification of systemic sclerosis
, and two considered to have primary Sjogrem's syndrome. We also included 24 controls, seven in whom tests for serum ANA were ordered on clinical grounds (one with discoid lupus erythematosus and six with idiopathic Raynaud's phenomenon) and 17 in whom results of ANA would not be considered clinically relevant but in whom we felt the possibility of false-positive results by liposomal colorimetric assay deserved consideration. This latter group consisted of five individuals with treated syphilis and positive tests for serum VDRL, eight with end-stage renal disease, and four normal individuals.
Serologic studies. Sera from blood allowed to clot at room temperature were stored at -70 #{176}C and thawed just before the liposomal colorimetric assay. We used fresh samples for all serologic studies, which included tests by indirect immu- nofluorescence for ANA (mouse liver substrate; Meloy Laboratories, Springfield, VA 22151) and anti-ds DNA (Crithidia luciliae substrate; Bio-Dx, Morristown, NJ 07960). Although the results of the liposomal colorimetric assays were read without knowledge of the sample type, sera were not randomly collected but rather were collected to reflect a desired balance of known serologic reactivities.
Results and Discussion
Liposomal Colorimetric Assay
Large unilamellar liposomes composed of POPC, cardiolipin, cholesterol, DPPG, and a-tocopherol (3/4/1.9/1.0/0.1 mol ratio) and containing the divalemt cation-sensitive dye Affi within their aqueous spaces appear red. Hereafter we refer to these as cardiolipin-liposomes.
Addition of magnesium to these vesicles will break down the liposomal membrane, leading to the formation of a stable blue magnesiumAu complex. This phenomenon is not blocked in the presence of normal serum, but addition of SLE serum before the addition of magnesium will inhibit the magnesiumdependent lysis and thus block the red-to-blue color change, presumably because the lupus autoantibodies bind to the cardiolipin. Figure 1 shows spectral curves we established for cardiolipin-liposomes in the presence of both SLE and normal serum 5 mm after the addition of magnesium. The All-magnesium absorbance maximum at 610 nm was significantly decreased in the presence of SLE serum as compared with the curve generated when normal serum was added (0.4 vs 1.6 A). The visual perception of this absorbance difference is shown in Figure 2 .
Binding of Serum Proteins to Liposomes
To determine the extent of antibody binding to liposomes, we mixed liposomes with either normal sera or SLE sera as previously described and analyzed the absorbed proteins by gel electrophoresis (Figure 3) . We used three liposome compositions to determine whether the negative charge of cardiolipin liposomes was in itself sufficient to stimulate the binding of appropriate serum factors. In lanes 1 and 4 we analyzed the proteins bound primarily to lecithin liposomes (POPC substituted for cardiolipim). Obviously, under these conditions, virtually no discrete protein could be detected. The substitution of DPPG for cardiolipin (lanes 2 and 5) results in a substantial amount of protein bound to the liposomes after incubation in both normal and SLE sera. In fact, we could discern little, if any, difference in the banding patterns in these two lanes. Lanes 3 and 6 represent the proteins bound by cardiolipin-liposomes incubated with normal and SLE serum, respectively. Lane 6 (SLE serum) shows large increases in both the number and intensity of protein bands, with the most relevant being the massive accumulation of a 50 000-Da protein and the first presence of a noticeable band at 25 000 Da. In light of the denaturing conditions used on this gel, the 50000-and 25 000-Da proteins bound to the cardiolipin liposomes from SLE serum probably represent the heavy and light chains of immunoglobulin. This conclusion is supported by the fact that, although the SLE serum incubated with both POPC-and DPPG-substituted liposomes retained its ability to inhibit the magnesium-induced color change when mixed with standard red cardiolipin liposomes, the SLE serum incubated with cardiolipin-containing liposomes did not (Figure 3) .
Antibody Specificity
To determine the specificity of the antibody detected by the liposomal colorimetric assay, we added various amounts of di DNA, single-stranded DNA (ss DNA), polyinosinic acid Incubation and Mg additionas in Fig. I [an analog for polyphosphate (6)1, or polyvinyl sulfate, which has a polymeric negative charge, to SLE serum before testing with the liposome assay system (Table 1) . The chemical nature of the additive that best eliminated the ability of the SLE serum to inhibit the described color change was taken as evidence for the nature of the specific- Table 1 
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a Sensitivity = (no. of patients with positive tests/no. of patients tested) x 100. 5Nos. in parentheses indicate no. of patients giving positive test results (for sensitivity; or for specificity, no. of negative results) and total no. of patients in that group. cControls include tests done on serum from patients with syphilis, end-stage renal disease, and Raynaud's disease. Four normals were also included. dSpecificiy = (no. of patients with negative tests/no. of patients without SLE) x 100.
#{149} Excluding patients with SLE. 'Total population minus patients in whom ANA testing would not be performed in routine clinical testing. 
Clinical Trials
We compare the results of testing by the liposomal colorimetric assay with results of standard laboratory diagnostic tests for SLE (ANA, anti-ds DNA) in Table 2 . Nineteen of 21 SLE patients were successfully identified by the liposomal colorimetric assay in a blinded analysis. Although the liposomal assay was less sensitive than ANA (90.5% vs 100%) with this sample of SLE sera, the liposomal assay was more sensitive than anti-ds DNA, as determined by Crithidia luciliae immunofluorescence (CLIF), 90.5% vs 61.9%. Three false-positive results were obtained in the liposomal test: two patients with rheumatoid arthritis (one of whom had a low-titer and anti-ds DNA, 1:20), and in one normal control. liposomal colorimetric assay with that of ANA and the CLIF test. Specificities were calculated both for the total group of sera tested and for an adjusted control population, eliminating those 17 patients in whom ANA testing would be unlikely in routine clinical practice (syphilis, uremia, and normals).
As expected, positive results by serum ANA had low specificity in this sampling, whereas both the liposomal colorimetric assay and the assay of anti-ds DNA by CLIF had a comparably high specificity for the diagnosis of SLE. There was no apparent influence of age, sex, race, or ongoing medication on the results of the liposomal colorimetric assay. to the added magnesium, forming a stable blue Affl-Mg complex (A = 610 nm). In the presence of lupus autoantibodies, specific binding to cardiolipin occurs, thus blocking the cooperative larnellar-to-hexagonal rearrangement. In this case the liposomal membrane is stabilized and the All remains uncomplexed. As formulated here, the cardiolipin-based liposomal assay system is unusual, in that binding of antibody stabilizes the membrane rather than destabilizes it through complementmediated damage, as has been reported for other cardiolipin-based systems (18, 19). Such differences probably relate to differences in supramolecular structure.
Perspectives
In conclusion, this liposomal assay method may offer a substantial methodological advance over other assays currently available for the diagnosis of SLE. The liposomal system is more sensitive than the assays for ds-DNA, without losing specificity.
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